Literature DB >> 10934102

Serological diagnosis of idiopathic pulmonary alveolar proteinosis.

T Kitamura1, K Uchida, N Tanaka, T Tsuchiya, J Watanabe, Y Yamada, K Hanaoka, J F Seymour, O D Schoch, I Doyle, Y Inoue, M Sakatani, S Kudoh, A Azuma, T Nukiwa, T Tomita, M Katagiri, A Fujita, A Kurashima, S Kanegasaki, K Nakata.   

Abstract

Previously, we reported the specific occurrence of neutralizing autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF) in the bronchoalveolar lavage fluid from 11 Japanese patients with idiopathic pulmonary alveolar proteinosis (I-PAP). The autoantibody was also detected in sera from all 5 I-PAP patients examined. To determine that the existence of the autoantibody is not limited to the Japanese patients, we examined sera from 24 I-PAP patients in five countries and showed that the autoantibody was consistently and specifically present in such patients. Thus, detection of the autoantibody in sera can be used for diagnosis of I-PAP. To establish a simple and convenient method for diagnosis of I-PAP, we developed a novel latex agglutination test using latex beads coupled with recombinant human GM-CSF. GM-CSF binding proteins isolated from the sera using the latex beads were identified as the autoantibodies of IgG(1) and IgG(2). The titer of the autoantibody determined by this test correlated with that determined by ELISA. Agglutination was positive in 300-fold diluted sera from all 24 I-PAP patients, but negative in sera from four secondary PAP patients, two congenital PAP patients, 40 patients with other lung diseases, and 38 of 40 normal subjects. These results establish that the latex agglutination test is a reliable method for serological diagnosis of I-PAP with high sensitivity (100%) and specificity (98%).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934102     DOI: 10.1164/ajrccm.162.2.9910032

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  43 in total

1.  Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.

Authors:  P Latzin; M Tredano; Y Wüst; J de Blic; T Nicolai; B Bewig; F Stanzel; D Köhler; M Bahuau; M Griese
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Temporary remission of autoimmune pulmonary alveolar proteinosis after infectious episodes.

Authors:  Takehiko Kobayashi; Toru Arai; Masaki Hirose; Tomomi Homma; Akiko Matsumuro; Chikatoshi Sugimoto; Masanori Kitaichi; Masanori Akira; Yoshikazu Inoue
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test.

Authors:  Tracey L Bonfield; Nejimol John; Barbara P Barna; Mani S Kavuru; Mary Jane Thomassen; Belinda Yen-Lieberman
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

4.  A nonaggregating surfactant protein C mutant is misdirected to early endosomes and disrupts phospholipid recycling.

Authors:  Michael F Beers; Arie Hawkins; Jean Ann Maguire; Adam Kotorashvili; Ming Zhao; Jennifer L Newitt; Wenge Ding; Scott Russo; Susan Guttentag; Linda Gonzales; Surafel Mulugeta
Journal:  Traffic       Date:  2011-06-28       Impact factor: 6.215

5.  Pulmonary alveolar proteinosis in workers at an indium processing facility.

Authors:  Kristin J Cummings; Walter E Donat; David B Ettensohn; Victor L Roggli; Peter Ingram; Kathleen Kreiss
Journal:  Am J Respir Crit Care Med       Date:  2009-12-17       Impact factor: 21.405

6.  Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Authors:  Yoshikazu Inoue; Bruce C Trapnell; Ryushi Tazawa; Toru Arai; Toshinori Takada; Nobuyuki Hizawa; Yasunori Kasahara; Koichiro Tatsumi; Masaaki Hojo; Toshio Ichiwata; Naohiko Tanaka; Etsuro Yamaguchi; Ryosuke Eda; Kazunori Oishi; Yoshiko Tsuchihashi; Chinatsu Kaneko; Toshihiro Nukiwa; Mitsunori Sakatani; Jeffrey P Krischer; Koh Nakata
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

7.  [Classification of pulmonary alveolar proteinosis in newborns, infants, and children].

Authors:  F Brasch; K-M Müller
Journal:  Pathologe       Date:  2004-07       Impact factor: 1.011

8.  Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.

Authors:  Kanji Uchida; Koh Nakata; Takuji Suzuki; Maurizio Luisetti; Masato Watanabe; Diana E Koch; Carrie A Stevens; David C Beck; Lee A Denson; Brenna C Carey; Naoto Keicho; Jeffrey P Krischer; Yoshitsugu Yamada; Bruce C Trapnell
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

9.  [45-year old patient with progressive shortness of breath and "crazy paving"].

Authors:  S Langwieler; E Smektala; N Waldburg; T Hachenberg; D Küster; J Schreiber
Journal:  Internist (Berl)       Date:  2012-11       Impact factor: 0.743

10.  Clinical significance of anti-GM-CSF antibodies in idiopathic pulmonary alveolar proteinosis.

Authors:  F-C Lin; G-D Chang; M-S Chern; Y-C Chen; S-C Chang
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.